Monthly archive | PharmaTutor

29 November 2024

iBRIC-inStem invites applications for post of Junior Research Fellow, Project Associate

Masters Degree in Life Sciences, MVSC or Bachelors degree in Engineering or Technology or Medicine from a recognised university or equivalent. With 1 years of R&D experience in academic institution or relevant industry.

29 November 2024

PBTI invites applications for post of Research Fellow - Salary Rs. 40,000 pm

1st class Masters Degree in Biotechnology, Chemistry, Biochemistry, Food Science from a recognized University OR 1st class B. Tech Degree in Biotechnology, Food Technology from a recognized University

29 November 2024

Vacancy for Junior Research Fellow at ACTREC

To work on project in Translational Research Laboratory Area of research DNA damage repair and cancer. M.Sc. degree obtained after a one-year course will not be considered.

29 November 2024

Central University of Punjab Admission to PhD Program 2024-25 Academic Session

B.Pharmacy degree and Master degree M.Pharm, M.S Pharm, M.Sc. Pharmacology or equivalent with minimum of 55% marks

29 November 2024

Vacancy for M.Pharm, B.Pharm, MSc in Commercial Operations Department at JAMP Pharma group

Ensure projects are kicked off appropriately and required information defining the scope of the project is properly identified. Ensure that a project schedule encompassing project scope and associated details is accurately developed and regularly maintained.

29 November 2024

Walk In Drive for M.Pharm, B.Pharm, MSc in QA, QC, Production at Macleods Pharmaceuticals

2-8 years of experience in BMR, QMS, PQR, Qualification, AQA, ERP, Control Sample, Process Validation.

29 November 2024

Lupin Limited Walk in drive at Ahmedabad for B.Pharm, MSc in QC Department

Analyst worked in AMT, AMV section having exposure to HPLC, GC, IC, AAS. Analyst worked in GLP Section having exposure instrument calibration, Qualification, Standard Management, Working Standard qualification.

29 November 2024

New study reveals genetic drivers of early onset type 2 diabetes in South Asians 

The findings, published today in Nature Medicine, show that these genetic factors also lead to quicker development of health complications, earlier need for insulin treatment, and a weaker response to some medications. The results of this research, funded by Barts Charity and Wellcome, reinforce the need to understand how genetic variation across different population groups can influence the onset of diseases, treatment responses, and disease progression.

29 November 2024

Dr. Reddy's launches Toripalimab in India

Toripalimab is a New Biological Entity. It is the only immuno-oncology drug approved by various regulatory authorities around the world such as the United States Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma.